Hamlet PharmaHamlet PharmaHamlet Pharma
  • Home
  • About Hamlet Pharma
    • Finance and Strategy
    • Patents
    • Who Gets Cancer
  • Clinical Trials
  • Science
  • Investors
    • Financial Reports
    • Extra bolagsstämma 2 mars 2021
  • News
  • Contact
Hamlet Pharma
Category

Pressmeddelande

PressmeddelandeUncategorized

Kommuniké från extra bolagsstämma i Hamlet Pharma

Pressmeddelande

Kallelse till extra bolagsstämma i Hamlet Pharma

Pressmeddelande

Pressmeddelande, 29 januari 2021, Lund

NewsPressmeddelande

Dose-escalation study initiated

Pressmeddelande

Kallelse till Årsstämma i Hamlet Pharma AB (publ)

NewsPressmeddelande

Hamlet Pharma-BC Kick-off meeting

NewsPressmeddelande

Hamlet Pharma Starts Two Parallel Clinical Study Programs

NewsPressmeddelande

Hamlet Pharma regains patent rights for BAMLET

NewsPressmeddelande

Hamlet Pharma builds for a promising future

NewsPressmeddelande

Hamlet Pharma enters into Patent Licensing Agreement

1 2 Next

HAMLET Pharma AB is a pharmaceutical company with strong links to research, working with natural and biological substances.

Swedish

© 2021 Hamlet Pharma.

  • Home
  • About Hamlet Pharma
    • Finance and Strategy
    • Patents
    • Who Gets Cancer
  • Clinical Trials
  • Science
  • Investors
    • Financial Reports
    • Extra bolagsstämma 2 mars 2021
  • News
  • Contact

Hamlet Pharma AB

BMC D10
Klinikgatan 32
SE-222 42 Lund, Sweden
+46 40 12 25 00
info@hamletpharma.com

Swedish